by Aamir Manan Deva
The egg controversy exposes India’s acceptance of permissible risk, regulatory compromise over precaution, divergence from global standards, and eroding public trust in food safety governance
India is not debating eggs per se; it is debating the degree to which it is willing to quietly normalise risk. The contemporary controversy surrounding nitrofuran residues in eggs has been reduced to a binary frame: either eggs are suddenly carcinogenic, or everything is acceptable because detected residues lie “within permissible limits” established by the apex authority in the country; Food Safety and Standards Authority of India (FSSAI). Both extremes are intellectually dishonest. The substantive issue lies elsewhere in how Indian regulators define safety, and why that definition increasingly diverges from global food safety standards.
Nitrofurans are not esoteric chemicals. They are prohibited antibiotics, classified as genotoxic carcinogens by multiple international agencies. The European Union and several other jurisdictions adhere to a zero-tolerance policy, not because they believe that food can be absolutely chemically pure, but because any detectable residue is deemed unacceptable when safer production systems exist. In contrast, India allows up to 1 ppm. The recent result of about 0.73 ppm thus did not constitute a regulatory breach. Legally, that settles the matter. Ethically, it should not.
Using Banned Chemicals
Why does India permit what others ban? The explanation is uncomfortable but straightforward: Indian regulations of food safety are directed more at feasibility than precaution. Standards are defined more by capacity for enforcement, size of the market, and fear of disruption rather than toxicology. And when regulators cannot ensure uniform quality testing, proper traceability systems, and upstream accountability, they hedge, but not in favour of consumers, in favour of manageability.
This is not regulatory negligence. It is a regulatory compromise. Yet compromises carry consequences. By establishing numerical thresholds instead of detection-based standards, the system quietly converts “banned” substances into “tolerated” ones-so long as they remain below a line drawn for administrative convenience.
Over time, this trains both producers and consumers to accept low-level exposure as normal, inevitable, even harmless. The deeper problem lies not in the limit itself but in the mismatch between regulation and representation. Firms operating within FSSAI norms are legally compliant. Yet when compliance is packaged as moral superiority-“antibiotic-free,” “chemical-free,” “clean food”-the ground shifts. A claim of purity ceases to be about minimum safety and becomes a claim about maximum trust.
An Enigmatic Silence
In this regard, the Apex regulatory Authority is conspicuously silent. FSSAI is stringent about what may be sold but markedly lax about what may be promised. This enables firms to inhabit a convenient grey zone: aspirational purity in the market while defending themselves with technical legality. When consumers perceive misalignment, regulators retreat behind permissible limits, as if legality alone suffices to sustain credibility. It does not.
The public response, often labelled as hysteria, demands closer examination. Indians are not turning against science. They are asking a fair question: why do our food safety standards stay under scrutiny when drugs banned elsewhere are still allowed here in small amounts? This concern grows sharper when consumers are asked to pay extra for “premium” or “antibiotic-free” food. That is not panic or ignorance. It is a reasonable demand for consistency between what is promised, what is regulated, and what is delivered.
There is no solid evidence that eating eggs within current safety limits causes cancer. Most experts agree that eggs, when eaten in moderation, are not carcinogenic and are, in fact, rich in protein, vitamins, and other beneficial nutrients. This is not a case for panic. But neither is it a case for complacency. When regulators repeatedly brush aside differences with global standards instead of addressing them, public trust in food safety slowly wears away.
What Must Be Done?
If the country wants to avoid a cycle of recurring food scares—recently frozen poultry and meat in Kashmir, questions around traditional foods like wazwaan, now eggs, mand, inevitably milk, packaged drinking water next- it must pause and reassess three core aspects of its food safety framework. These concerns are emerging precisely because the consumer base for processed, packaged, and premium food products is expanding rapidly, and expectations of safety and transparency are rising with it.
First, claims must have consequences. Any producer advertising food as “antibiotic-free” should be required to meet zero-detection standards in line with international food safety norms. If the system cannot enforce this yet, such claims should not be permitted at all. Although these rules exist on paper, monitoring remains weak, and problems often surface only when they go viral in the public domain. Aspirational marketing cannot be allowed to run ahead of regulatory reality.
Second, the system needs to be ready to move beyond static ppm limits. As laboratory capacity improves, standards must begin to shift toward detection-based thresholds. Regulation must evolve with science, not freeze because enforcement is inconvenient.
Thirdly, FSSAI needs to communicate risk honestly. Permissible limits must be publicly justified, their review periodic, and their links with health outcomes transparent, not treated as bureaucratic absolution. India’s food system long worked on a logic of sufficiency: enough calories, enough protein, enough supply. That era is ending.
Citizens now ask more serious questions-not just “Is it legal?” but “Is it credible?” and “Is it necessary to accept this risk at all?” The egg controversy will subside. The discomfort it reveals should not. A regulator that becomes too comfortable with “permissible risk” ultimately finds that public trust lies beyond the permissible margin.
(The author is a Public Policy Adviser at Atal Bihari Vajpayee Institute of Good Governance and Policy Analysis, Bhopal, where he leads Projects on Impact assessments and policy analysis for government departments, translating research into sharp, actionable recommendations for evidence-based policy reforms. The ideas are personal.)
